{"entity":{"id":"nct07529717","kind":"trial","name":"First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer","aka":["CRIUS-1"],"tldr":"A phase 1/2 trial of AZD8359 in prostate cancer, run by AstraZeneca, now recruiting.","summary":"First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer is a phase 1/2 interventional study registered as NCT07529717 by AstraZeneca, with 42 participants planned, started 2026-05-18 and due to reach its primary completion in 2027-11-17. Interventions recorded: AZD8359.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07529717","url":"https://clinicaltrials.gov/study/NCT07529717"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["prostate"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["astrazeneca"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07529717","phase":"1/2","setting":"Phase I/II Dose Escalation & Dose Optimization Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD8359, a CD8-guided T Cell-engaging Antibody That Targets STEAP2, in Adult Participants With Prostate Cancer","sponsor":"AstraZeneca","participation":[{"nct":"NCT07529717","source":"https://clinicaltrials.gov/study/NCT07529717","fetchedAt":"2026-10-07T16:55:48.292Z","studySha256":"ca55d5bf95e5a5d8a99712146f0dd8e3ebbb2e8d9137932a91d764cedd69aabd","overallStatus":"RECRUITING","lastUpdatePosted":"2026-09-09","leadSponsor":"AstraZeneca","collaboratorCount":0,"minimumAge":"18 Years","maximumAge":"100 Years","sex":"MALE","healthyVolunteers":false,"hasEligibility":true,"enrolment":42,"enrolmentType":"ESTIMATED","siteCount":8,"recruitingSiteCount":7,"countries":["Australia","South Korea","United States"]}],"started":"2026-05-18","startedType":"actual","enrolled":42,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07529717/","neighbours":{"cancer":[{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"company":[{"id":"astrazeneca","kind":"company","name":"AstraZeneca","route":"/companies/astrazeneca/"}]}}